TY  - GEN
AU  - Qin,Shukui
AU  - Chan,Stephen Lam
AU  - Sukeepaisarnjaroen,Wattana
AU  - Han,Guohong
AU  - Choo,Su Pin
AU  - Sriuranpong,Virote
AU  - Pan,Hongming
AU  - Yau,Thomas
AU  - Guo,Yabing
AU  - Chen,Minshan
AU  - Ren,Zhenggang
AU  - Xu,Jianming
AU  - Yen,Chia-Jui
AU  - Lin,Zhong-Zhe
AU  - Manenti,Luigi
AU  - Gu,Yi
AU  - Sun,Yongjian
AU  - Tiedt,Ralph
AU  - Hao,Lu
AU  - Song,Wenjie
AU  - Tanwandee,Tawesak
TI  - A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
SN  - 1758-8340
PY  - 2019///
PB  - Therapeutic advances in medical oncology
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1177/1758835919889001
ER  -